| 货号 | 9935T |
| 目标/特异性 | Each antibody in the kit detects endogenous levels of Src only when in the indicated phosphorylation state at the indicated residue. The antibodies may cross-react with other Src family members when in equivalent phosphorylation states. |
| 供应商 | CST |
| 背景 | The Src family of protein tyrosine kinases, which includes Src, Lyn, Fyn, Yes, Lck, Blk, and Hck, are important in the regulation of growth and differentiation of eukaryotic cells (1). Src activity is regulated by tyrosine phosphorylation at two sites, but with opposing effects. While phosphorylation at Tyr416 in the activation loop of the kinase domain upregulates enzyme activity, phosphorylation at Tyr527 in the carboxy-terminal tail by Csk renders the enzyme less active (2). |
| 存放说明 | -20C |
| 参考文献 | Thomas, S.M. and Brugge, J.S. (1997) Annu Rev Cell Dev Biol 13, 513-609. Hunter, T. (1987) Cell 49, 1-4. Yamanashi, Y. et al. (1989) Proc. Natl. Acad. Sci. USA 86, 6538-6542. Yamanashi, Y. et al. (1991) Science 251, 192-194. Molina, T. J. et al. (1992) Nature 357, 161-164. Straus, D. B. et al. (1992) Cell 70, 585-593. Chow, L. M. et al. (1993) Nature 365, 156-160. |
Western blot analysis of cell extracts from various cell lines, using Src (32G6) Rabbit mAb #2123. | |
Western blot analysis of cell extracts from various cell lines, using Src (32G6) Rabbit mAb. | |
Western blot analysis of extracts NIH/3T3 cells, serum-starved or treated with human Platelet-Derived Growth Factor BB hPDGF-BB #8912 (100 ng/ml, 15 min), using Phospho-Src Family (Tyr416) (D49G4) Rabbit mAb (upper) or Src (36D10) Rabbit mAb #2109 (lower). | |
Immunofluorescent staining of MCF-7 cells, using Src (36D10) Rabbit mAb #2109 alone (A), or the same antibody after a 1 hour preincubation with antigenic peptide (B). | |
Immunohistochemical analysis of paraffin-embedded human breast carcinoma, using Src (36D10) Rabbit mAb in the presence of control peptide (left) or antigen-specific peptide (right). | |
Western blot analysis of extracts NIH/3T3 cells, serum-starved or treated with human Platelet-Derived Growth Factor BB hPDGF-BB #8912 (100 ng/ml, 15 min), using Phospho-Src Family (Tyr416) (D49G8) Rabbit mAb #6943 (upper) or Src (36D10) Rabbit mAb #2109 (lower). | |
Western blot analysis of extracts from NIH/3T3 cells, using Phospho-Src (Tyr527) Antibody #2105 (A, B) or v-Src antibody (C, D). The phospho-specificity of the antibody was determined by treating the membrane with (B, D) or without (A, C) calf intestinal alkaline phosphatase (CIP) after Western transfer. | |
Immunohistochemical staining of paraffin-embedded human breast carcinoma, showing membrane localization of phosphorylated Src, using Phospho-Src (Tyr527) Antibody #2105. | |
Western blot analysis of extracts from A431 cells, untreated or pervanidate-treated (1 mM, 15 minutes), using Non-phospho-Src (Tyr527) Antibody #2107 (upper) or v-Src antibody (lower). | |
Western blot analysis of extracts from pervanadate-treated (1 mM for 5 minutes) NIH/3T3 cells that have been stably transfected with a constitutively active form of Src (in which the regulatory tyrosine 527 residue has been mutated to phenylalanine), A431 cells and HepG2 cells, using Non-phospho-Src (Tyr416) (7G9 ) mAb #2102 (upper), v-Src antibody (middle) or Phospho-Src (Tyr416) Antibody #2101 (lower). | |
Immunohistochemical analysis of paraffin-embedded human breast carcinoma, showing membrane and cytoplasmic localization using Phospho-Src (Tyr527) Antibody. | |
Western blot analysis of extracts from A431 cells, untreated or pervanadate-treated (1 mM for 15 minutes), using Non-phospho-Src (Tyr527) Antibody (upper) or v-Src antibody (lower). | |
Western blot analysis of extracts from pervanadate-treated (1 mM for 5 minutes) NIH/3T3 cells that have been stably transfected with a constitutively active form of Src (in which the regulatory tyrosine 527 residue has been mutated to phenylalanine), A431 cells and HepG2 cells, using Non-phospho-Src (Tyr416) (7G9 ) Mouse mAb (top), v-Src antibody (middle) or Phospho-Src (Tyr416) Antibody #2101 (bottom). | |
After the primary antibody is bound to the target protein, a complex with HRP-linked secondary antibody is formed. The LumiGLO* is added and emits light during enzyme catalyzed decomposition. | |
After the primary antibody is bound to the target protein, a complex with HRP-linked secondary antibody is formed. The LumiGLO* is added and emits light during enzyme catalyzed decomposition. |
